PRKS Heads Into Earnings With Shorts Retreating and Options Turning Bullish
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
United Parks & Resorts reports Q3 results tomorrow morning with a quietly contradictory setup: short sellers have been covering steadily for a month, options have shifted more bullish than they have been in over a year, and an activist sits on more than 60% of the company.
The most striking single data point this week is in options. The put/call ratio has dropped sharply to 1.36, nearly four standard deviations below its 20-day average of 1.99. That is the least defensive options positioning seen on PRKS in at least 12 months, sitting close to the 52-week low of 0.007. The move is a clean contrast with the prior several weeks, when the PCR ran above 2.0 consistently. Options traders appear to have unwound a significant amount of downside protection heading into the print.
The short side tells a similar story. Short interest has fallen roughly 14% over the past month to 8.9% of free float, down from levels above 10% in early October. The drop between October 22 and October 26 was particularly sharp, with shorts shedding nearly a million shares in a few sessions. Borrow cost is low at 0.57%, easing about 5% on the week. Availability has loosened considerably too, rising to 81% from roughly 63% a fortnight ago and well above the 52-week trough of 40%. The borrow market is not under pressure. Combined, the picture is of a measured short-covering rally rather than a squeeze, with the lending pool comfortable and no sign of forced buying.
The Street is split but leans cautious on valuation. The mean price target is $45.30 against a close of $32.55, implying about 39% nominal upside. But the most recent material move came from Citigroup's James Hardiman in early October, who slashed his target from $49 to $34 while keeping a Neutral rating, a rare bellwether cut in the weeks before an earnings print. Before that, most of August's activity was constructive: JP Morgan, Guggenheim and Barclays all lifted targets after the prior quarter's results. The stock trades at roughly 7.7x earnings and 6.3x EV/EBITDA, modest multiples that the bull case frames as a discount to regional theme park peers. The bear case centres on flat attendance trends, reduced estimates and macro headwinds to discretionary spending. Factor scores back the value angle: earnings yield ranks in the 88th percentile of the ORTEX universe. EPS momentum over both 30 and 90 days is solid, in the 68th and 61st percentiles respectively.
The most structurally important ownership fact is not in a fund filing. Scott Ross, through Hill Path Capital Partners, has filed a Schedule 13D/A showing a stake of 60.2% of the company, up from 57.9% in the prior filing dated August 11. That is an activist at controlling-shareholder scale, not a minority agitator. Hill Path has been on the register since mid-2025 and has filed five times. As the disclosure note requires: 13D/G positions are event-driven around the 5% threshold, and the stake is as last disclosed. Still, with a 10% owner also named in recent insider filings receiving share awards alongside the CEO and several directors, the ownership structure is tightly concentrated. The 90-day insider net is a modest negative at approximately minus $334,000, but the recent transactions flagged are all compensation awards, code-A grants rather than open-market sales, so they carry limited conviction signal.
Wikipedia attention for PRKS is running at a z-score of 2.1 against its own prior 90 days, the highest retail attention reading in that window. That is worth noting as colour ahead of the print, though the alt-data layer carries no measured lead dataset for PRKS, so the attention signal is not predictive of the revenue line.
The past two quarterly prints produced muted next-day reactions: a 2.2% drop after the August 2026 release and a 1.2% gain after the one before it. Five-day moves were similarly contained, both hovering around minus 2 to minus 3%. With the PCR at a 12-month low and short interest well off its recent peak, tomorrow's reaction will show whether the pre-earnings optimism in derivatives was well-placed or simply a positioning flush ahead of a cautious number.
Stocks in this article
See the live data behind this article on ORTEX.
Open PRKS on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 19:54
- Data as of
- 4 Nov 2026, 19:51
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.